<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03212872</url>
  </required_header>
  <id_info>
    <org_study_id>30142/03/31</org_study_id>
    <nct_id>NCT03212872</nct_id>
  </id_info>
  <brief_title>Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding</brief_title>
  <acronym>EV</acronym>
  <official_title>Evaluation of Blood Ammonia Level as a Non Invasive Predictor for Presence of Gastroesophageal Varices and Risk of Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of blood ammonia level as a non-invasive predictor for presence of EV and risk of&#xD;
      bleeding&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective cross sectional study on 150 consecutive patients screening for esophageal&#xD;
      varices.&#xD;
&#xD;
      Patient groups groups:&#xD;
&#xD;
      Group (1): 100 patients with esophageal varices&#xD;
&#xD;
      Group (2): 50 chronic liver disease patients with no esophageal varices as a control group.&#xD;
&#xD;
      All patients will be subjected to:&#xD;
&#xD;
        1. - Detailed history-taking&#xD;
&#xD;
        2. - Full clinical examination&#xD;
&#xD;
        3. - Laboratory investigations:&#xD;
&#xD;
             -  Complete blood picture (CBC)&#xD;
&#xD;
             -  Erythrocyte sedimentation rate (ESR)&#xD;
&#xD;
             -  Renal function tests&#xD;
&#xD;
             -  Liver function tests&#xD;
&#xD;
             -  Prothrombin time and activity&#xD;
&#xD;
             -  Viral markers (HCV Ab - HBV Ag)&#xD;
&#xD;
             -  Blood ammonia level.&#xD;
&#xD;
        4. - Pelviabdominal US: Ultrasound examination of the liver, portal venous system, spleen,&#xD;
           kidney and other abdominal organs.&#xD;
&#xD;
        5. - Upper GITendoscopy:&#xD;
&#xD;
             -  Varices will be classified according to the Japanese classification 1996,&#xD;
&#xD;
             -  The Baveno 11 score will be used to differentiate between mild and severe portal&#xD;
                hypertensive gastropathy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 7, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>level of serum ammonia in patients with risk factors for bleeding from esophageal varices</measure>
    <time_frame>24 months</time_frame>
    <description>estimation of level of serum ammonia in patients with risk factors for bleeding from esophageal varices</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Chronic Liver Disease</condition>
  <condition>Esophageal Varices</condition>
  <arm_group>
    <arm_group_label>Endoscopy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endoscopy</intervention_name>
    <arm_group_label>Endoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with chronic liver disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient in hepatic encephalopathy or coma.&#xD;
&#xD;
          -  Patient in active bleeding or with history of bleeding within the two weeks prior to&#xD;
             entry in the study .&#xD;
&#xD;
          -  Patients with heart failure.&#xD;
&#xD;
          -  Patients with renal failure.&#xD;
&#xD;
          -  Patient with hepatocellular carcinoma and portal vein thrombosis.&#xD;
&#xD;
          -  Patient taking Beta blockers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ferial El-Kalla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tanta University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ferial El-Kalla, MD</last_name>
    <phone>00201006023289</phone>
    <email>f.elkalla@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tanta Faculty of Medicine</name>
      <address>
        <city>Tanta</city>
        <state>Gharbiah</state>
        <zip>35127</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferial El-kalla, MD</last_name>
      <phone>002010060232</phone>
      <email>f.elkalla@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Loai Mansour, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abdelrahman Kobtan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asmaa Elziftawy, MBBCH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>July 7, 2017</study_first_submitted>
  <study_first_submitted_qc>July 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>July 7, 2017</last_update_submitted>
  <last_update_submitted_qc>July 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Ferial El-Kalla</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Ammonia</keyword>
  <keyword>bleeding risk factors</keyword>
  <keyword>endoscopic risk signs for bleeding</keyword>
  <keyword>esophageal varices</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

